Pharmaceutical

Market cap upturn for top 20 biopharma companies with obesity drug successes in 2023

The top 20 biopharmaceutical companies saw prominent shifts in market capitalisation over 2023 despite various obstacles.

Mar 1, 2024 - 18:00
Market cap upturn for top 20 biopharma companies with obesity drug successes in 2023
The top 20 biopharmaceutical companies saw prominent shifts in market capitalisation over 2023 despite various obstacles.
Read the original article

Tags:

Previous Article

Green granulation: Tracking energy efficiency in pharmaceutical granulation

Next Article

FDA lifts two-year clinical hold on CytoDyn’s HIV trial

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Fujifilm invests $1.2bn ramping up North Carolina facility

Fujifilm invests $1.2bn ramping up North Carolina facility

Apr 13, 2024

RiMO-301 by Rimo Therapeutics for Recurrent Head And Ne...

Dec 4, 2023

STAT+: Cancer drug shortages won’t get better under Biden’s latest plan

STAT+: Cancer drug shortages won’t get better under Bid...

Dec 5, 2023